Markets & news

COMPANY PROFILE

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business Support MCap (Rs. in Mn) : 63671.14 Face Value (Rs.) : 1 House : Sun Pharma
BSECurrent Price (Rs.) 196.20Change (Rs.)10.9 (+5.88 %)
PREV CLOSE (Rs.) 185.30
OPEN PRICE (Rs.) 185.90
BID PRICE (QTY) 195.60 (1)
OFFER PRICE (QTY) 195.75 (1)
VOLUME 168304
TODAY'S LOW / HIGH (Rs.)185.90 199.95
52 WK LOW / HIGH (Rs.)108.2 289
NSECurrent Price (Rs.) 196.16Change (Rs.)10.83 (+5.84 %)
PREV CLOSE( Rs. ) 185.33
OPEN PRICE (Rs.) 185.49
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 196.16 (686)
VOLUME 2319032
TODAY'S LOW / HIGH(Rs.) 185.49 200.09
52 WK LOW / HIGH (Rs.)108 289
GO

Financial Ratios

Particulars
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Operational & Financial Ratios
 
 
 
 
   Earnings Per Share (Rs)
47.86  
-10.55  
-11.93  
-6.86  
   CEPS(Rs)
48.17  
-10.17  
-11.55  
-6.50  
   DPS(Rs)
0.00  
0.00  
0.00  
0.00  
   Book NAV/Share(Rs)
41.25  
-6.68  
3.88  
15.80  
   Tax Rate(%)
-0.01  
0.08  
-0.10  
0.00  
Margin Ratios
 
 
 
 
   Core EBITDA Margin(%)
85.08  
-450.27  
-532.26  
-89.65  
   EBIT Margin(%)
84.46  
-465.04  
-509.81  
-90.02  
   Pre Tax Margin(%)
82.64  
-477.64  
-512.05  
-93.22  
   PAT Margin (%)
82.65  
-477.26  
-512.56  
-93.22  
   Cash Profit Margin (%)
83.20  
-459.99  
-496.00  
-88.29  
Performance Ratios
 
 
 
 
   ROA(%)
124.17  
-80.88  
-57.63  
-26.81  
   ROE(%)
276.89  
0.00  
-121.28  
-43.41  
   ROCE(%)
163.94  
-311.92  
-112.35  
-41.91  
   Asset Turnover(x)
1.50  
0.17  
0.11  
0.29  
   Sales/Fixed Asset(x)
12.44  
0.46  
0.50  
1.63  
   Working Capital/Sales(x)
1.70  
-0.21  
17.46  
0.87  
Efficiency Ratios
 
 
 
 
   Fixed Capital/Sales(x)
0.08  
2.20  
2.01  
0.61  
   Receivable days
2.36  
80.33  
116.55  
50.01  
   Inventory Days
0.00  
0.00  
0.00  
0.00  
   Payable days
NA  
NA  
NA  
NA  
Valuation Parameters
 
 
 
 
   PER(x)
2.39  
0.00  
0.00  
0.00  
   PCE(x)
2.38  
-14.55  
-32.04  
-27.62  
   Price/Book(x)
2.78  
-22.14  
95.47  
11.36  
   Yield(%)
0.00  
0.00  
0.00  
0.00  
   EV/Net Sales(x)
2.27  
70.50  
157.49  
23.92  
   EV/Core EBITDA(x)
2.66  
-15.74  
-31.93  
-28.11  
   EV/EBIT(x)
2.69  
-15.16  
-30.89  
-26.57  
   EV/CE(x)
2.26  
122.69  
68.87  
11.14  
   M Cap / Sales
1.98  
66.93  
158.92  
24.39  
Growth Ratio
 
 
 
 
   Net Sales Growth(%)
2518.47  
-5.00  
-68.36  
0.00  
   Core EBITDA Growth(%)
600.93  
13.76  
-83.40  
0.00  
   EBIT Growth(%)
575.56  
13.34  
-79.18  
0.00  
   PAT Growth(%)
553.48  
11.55  
-73.96  
0.00  
   EPS Growth(%)
553.48  
11.55  
-73.96  
0.00  
Financial Stability Ratios
 
 
 
 
   Total Debt/Equity(x)
0.42  
-1.19  
0.37  
0.00  
   Current Ratio(x)
2.47  
0.07  
1.02  
2.54  
   Quick Ratio(x)
2.47  
0.07  
1.02  
2.54  
   Interest Cover(x)
46.50  
-36.92  
-227.27  
-28.15  
   Total Debt/Mcap(x)
0.15  
0.05  
0.00  
BACK TO TOP